179 related articles for article (PubMed ID: 31823177)
21. 2019 White Paper on Recent Issues in Bioanalysis: Chromatographic Assays (Part 1 - Innovation in Small Molecules and Oligonucleotides & Mass Spectrometric Method Development Strategies for Large Molecule Bioanalysis).
Fandozzi C; Evans C; Wilson A; Su D; Anderson M; Clausen V; Dillen L; Garofolo F; Holliman C; Nickbarg E; Olah T; Ramanathan R; Zhang H; Kaur S; Pillutla R; Yu H; Bateman K; Donato LD; Hengel S; Jian W; Jones B; Kellie J; Lee A; Palandra J; Savoie N; Shipkova P; Spitz S; Su D; Szapacs M; Wang J; Wright K; Zeng J
Bioanalysis; 2019 Nov; 11(22):2029-2048. PubMed ID: 31808716
[TBL] [Abstract][Full Text] [Related]
22. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
Pflieger M; Bertram D
Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
[TBL] [Abstract][Full Text] [Related]
23. Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: issues of international harmonization.
O'Neill RT
Stat Med; 1995 May 15-30; 14(9-10):117-27. PubMed ID: 7569506
[TBL] [Abstract][Full Text] [Related]
24. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.
Viswanathan CT; Bansal S; Booth B; DeStefano AJ; Rose MJ; Sailstad J; Shah VP; Skelly JP; Swann PG; Weiner R
Pharm Res; 2007 Oct; 24(10):1962-73. PubMed ID: 17458684
[TBL] [Abstract][Full Text] [Related]
25. Perspectives on the draft ICH-M10 guidance: an interview with John Kadavil.
Kadavil J
Bioanalysis; 2019 Nov; 11(22):2027-2028. PubMed ID: 31637933
[TBL] [Abstract][Full Text] [Related]
26. Conference report: AAPS and US FDA Crystal City V meeting on Quantitative Bioanalytical Method Validation and Implementation: feedback from the EBF.
Smeraglia J; McDougall S; Elsby K; Companjen A; White S; Golob M; Brudny-Kloeppel M; Amsterdam Pv; Timmerman P
Bioanalysis; 2014 Mar; 6(6):729-32. PubMed ID: 24702107
[TBL] [Abstract][Full Text] [Related]
27. The global bioequivalence harmonisation initiative: Report of EUFEPS/AAPS third conference.
Mehta M; Blume H; Beuerle G; Tampal N; Schug B; Potthast H; Jiang W; Wilson C
Eur J Pharm Sci; 2020 Aug; 151():105383. PubMed ID: 32473200
[TBL] [Abstract][Full Text] [Related]
28. 2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles
Sumner G; Keller S; Huleatt J; Staack RF; Wagner L; Azadeh M; Bandukwala A; Cao L; Du X; Salinas GF; Garofolo F; Harris S; Hopper S; Irwin C; Ji Q; Joseph J; King L; Kinhikar A; Lu Y; Luo R; Mabrouk O; Malvaux L; Marshall JC; McGuire K; Mikol V; Neely R; Qiu X; Saito Y; Salaun B; Scully I; Smeraglia J; Solstad T; Stoop J; Tang H; Teixeira P; Wang Y; Wright M; Mendez L; Beaver C; Eacret J; Au-Yeung A; Decman V; Dessy F; Eck S; Goihberg P; Alcaide EG; Gonneau C; Grugan K; Hedrick MN; Kar S; Sehra S; Stevens E; Stevens C; Sun Y; McCush F; Williams L; Fischer S; Wu B; Jordan G; Burns C; Cludts I; Coble K; Grimaldi C; Henderson N; Joyce A; Lotz G; Lu Y; Luo L; Neff F; Sperinde G; Stubenrauch KG; Wang Y; Ware M; Xu W
Bioanalysis; 2023 Aug; 15(15):861-903. PubMed ID: 37584363
[TBL] [Abstract][Full Text] [Related]
29. Perspectives on the draft ICH-M10 guidance: an interview with Mark Arnold.
Arnold ME
Bioanalysis; 2019 Aug; 11(15):1379-1382. PubMed ID: 31490110
[TBL] [Abstract][Full Text] [Related]
30. 2022 White Paper on Recent Issues in Bioanalysis: FDA Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, LNP & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolongation Effect, ADA Affinity, Risk-based Approaches, NGS, qPCR, ddPCR Assays (
Pan L; Mora J; Walravens K; Wagner L; Hopper S; Loo L; Bettoun D; Bond S; Dessy F; Downing S; Garofolo F; Gupta S; Henderson N; Irwin C; Ishii-Watabe A; Kar S; Jawa V; Joseph J; Malvaux L; Marshall JC; McDevitt J; Mohapatra S; Seitzer J; Smith J; Solstad T; Sugimoto H; Tounekti O; Wu B; Wu Y; Xu Y; Xu J; Yamamoto T; Yang L; Torri A; Kirshner S; Maxfield K; Vasconcelos JP; Abhari MR; Verthelyi D; Brodsky E; Carrasco-Triguero M; Kamerud J; Andisik M; Baltrukonis D; Bivi N; Cludts I; Coble K; Gorovits B; Gunn GR; Gupta S; Millner AH; Joyce A; Kubiak RJ; Kumar S; Liao K; Manangeeswaran M; Partridge M; Pine S; Poetzl J; Rajadhyaksha M; Rasamoelisolo M; Richards S; Song Y; Swanson S; Thacker S; Wadhwa M; Wolf A; Zhang L; Zhou L
Bioanalysis; 2023 Jul; 15(14):773-814. PubMed ID: 37526071
[TBL] [Abstract][Full Text] [Related]
31. Summary Report of a Public Workshop: Case Studies of Multi-Regional Clinical Trial Incorporating Concept of the ICH E17 Guideline.
Matsushima N; Otsubo Y; Aoi Y; Nakamura R; Kaneko S; Asakawa T; Matsuoka N; Watabe K; Komiyama O; Yamamoto H; Ando Y
Clin Pharmacol Ther; 2024 May; 115(5):965-970. PubMed ID: 38251824
[TBL] [Abstract][Full Text] [Related]
32. The European Bioanalysis Forum community's evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation.
van Amsterdam P; Companjen A; Brudny-Kloeppel M; Golob M; Luedtke S; Timmerman P
Bioanalysis; 2013 Mar; 5(6):645-59. PubMed ID: 23484783
[TBL] [Abstract][Full Text] [Related]
33. 2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation (
Corsaro B; Yang TY; Murphy R; Sonderegger I; Exley A; Bertholet S; Dakappagari N; Dessy F; Garofolo F; Kierstead L; Koch H; Sarikonda G; Savoie N; Siggers R; Solstad T; Lu Y; Milton M; Marshall JC; DelCarpini J; Gorovits B; Gupta S; Jesaitis L; Kamerud J; Kromminga A; Ma A; McNally J; Yan H; Wu B; Verthelyi D; Kirshner S; Pedras-Vasconcelos J; Rajadhyaksha M; Staack RF; Cherry E; Cludts I; Dahlbäck M; Gunn GR; Ishii-Watabe A; Jawa V; Kubiak R; Partridge M; Petrillo M; Pine SO; Poetzl J; Song S; Stebbins C; Wu Y; Zhang L; Kar S; Liang M; Abhari MR; Schweighardt B; Stubenrauch K; Xu Y
Bioanalysis; 2021 Mar; 13(6):415-463. PubMed ID: 33533276
[TBL] [Abstract][Full Text] [Related]
34. Perspectives on the draft ICH M10 guidance: an interview with Kelly Dong.
Dong K
Bioanalysis; 2019 Nov; 11(22):2025-2026. PubMed ID: 31645114
[TBL] [Abstract][Full Text] [Related]
35. Open forum conference on the ICH M13A bioequivalence guideline.
Blume H; Wedemeyer S; Seidlitz A; Beuerle G; Klein S; Bilensoy E
Eur J Pharm Sci; 2024 May; 196():106741. PubMed ID: 38452875
[TBL] [Abstract][Full Text] [Related]
36. The Global Bioequivalence Harmonization Initiative: Summary report for EUFEPS international conference.
Chen ML; Blume H; Beuerle G; Davit B; Mehta M; Potthast H; Schug B; Tsang YC; Wedemeyer RS; Weitschies W; Welink J
Eur J Pharm Sci; 2018 Jan; 111():153-157. PubMed ID: 28964950
[TBL] [Abstract][Full Text] [Related]
37. AAPS/RAPS/CAPRA collaborative program: exploring the challenges of drug regulation in a global environment: clinical concerns.
Martinez MN; McGilveray I
AAPS PharmSci; 2003 Oct; 5(4):E27. PubMed ID: 15198515
[TBL] [Abstract][Full Text] [Related]
38. 5th JBF Symposium: 'Bridging for a Global Harmonization'.
Kobayashi N
Bioanalysis; 2014; 6(19):2587-91. PubMed ID: 25411701
[TBL] [Abstract][Full Text] [Related]
39. [History of the discussion on ethnic difference at ICH].
Uchida E
Yakugaku Zasshi; 2009 Feb; 129(2):213-21. PubMed ID: 19182450
[TBL] [Abstract][Full Text] [Related]
40. Development and Regulatory Challenges for Peptide Therapeutics.
Zane D; Feldman PL; Sawyer T; Sobol Z; Hawes J
Int J Toxicol; 2021; 40(2):108-124. PubMed ID: 33327828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
